Luminex Corp. (LMNX) CEO Patrick J Balthrop buys 7,000 Shares

President & CEO of Luminex Corp. (LMNX, Financial) Patrick J Balthrop buys 7,000 shares of LMNX on 11/13/2009 at an average price of $13.23 a share.

Luminex Corporation has developed, manufactures and markets a proprietarytechnology that simplifies biological testing for the life sciences industry. This industry depends on a broad range of tests, called bioassays, to discover new drugs, identify new genes or simply monitor blood cholesterol levels. The LabMAP system simultaneously performs up to 100 bioassays on a single drop of fluid. Luminex Corp. has a market cap of $550.52 million; its shares were traded at around $13.27 with a P/E ratio of 120.64 and P/S ratio of 5.27.

LMNX is in the portfolios of PRIMECAP Management.

Insiders' Positions with LMNX

  • Buy:: Director Jay B Johnston bought 6,000 shares of LMNX stock on 11/11/2009 at the average price of 13.2, the price of the stock has increased by 0.53% since

  • Sell:: VP, Bioscience Group Gregory J Gosch sold 2,500 shares of LMNX stock on 09/16/2009 at the average price of 18, the price of the stock has decreased by 26.28% since

  • Sell:: VP, Bioscience Group Gregory J Gosch sold 2,500 shares of LMNX stock on 08/27/2009 at the average price of 15.55, the price of the stock has decreased by 14.66% since

  • Sell:: Director G Walter Ii Loewenbaum sold 10,000 shares of LMNX stock on 05/27/2009 at the average price of 15.65, the price of the stock has decreased by 15.21% since

  • Sell:: Director G Walter Ii Loewenbaum sold 15,486 shares of LMNX stock on 05/21/2009 at the average price of 15.47, the price of the stock has decreased by 14.22% since